Apixan Tablet 2.5 mg contains Apixaban 2.5 mg, an oral anticoagulant used to prevent and treat blood clots in patients at risk of thromboembolic events. Apixaban belongs to the direct oral anticoagulant (DOAC) class and works by selectively inhibiting Factor Xa, a key enzyme in the blood coagulation cascade. By doing so, it reduces the formation of harmful clots while maintaining normal hemostasis.

Apixan 2.5 mg is indicated for patients with conditions such as atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), or those at risk of clot formation after surgery. The low-dose tablet provides effective anticoagulation while minimizing the risk of bleeding, making it suitable for long-term use under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Apixaban 2.5 mg

Mechanism of Action

Apixaban is a selective Factor Xa inhibitor that works by:

• Blocking Factor Xa, an enzyme crucial for the conversion of prothrombin to thrombin

• Reducing thrombin generation, which prevents fibrin clot formation

• Maintaining a balance between clot prevention and normal blood flow

By targeting Factor Xa specifically, Apixaban provides anticoagulant effects without the frequent monitoring required for traditional therapies like warfarin.

Indications

Apixan Tablet 2.5 mg is prescribed for:

• Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation

• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Prevention of recurrent DVT and PE

• Postoperative thromboprophylaxis in patients undergoing hip or knee replacement surgery

• Patients at high risk of thromboembolic events requiring long-term anticoagulation

Benefits

• Effective Clot Prevention: Reduces risk of stroke, DVT, and PE

• Predictable Anticoagulant Effect: Fixed-dose therapy without routine coagulation monitoring

• Convenient Oral Administration: Once or twice daily dosing, depending on physician guidance

• Lower Bleeding Risk: Compared to traditional anticoagulants in properly selected patients

• Supports Long-Term Management: Safe for extended use under medical supervision

Dosage and Administration

• The typical dose is 2.5 mg twice daily for stroke prevention in atrial fibrillation or as recommended for DVT/PE prevention

• Tablets should be swallowed whole with water, with or without food

• Consistent dosing and adherence are essential to maintain anticoagulation effectiveness

• Dose adjustments may be required in patients with renal impairment, low body weight, or concomitant medications

• Do not stop therapy abruptly without consulting a healthcare provider, as this may increase the risk of clot formation

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• Common side effects include minor bleeding, bruising, or gastrointestinal discomfort

• Serious risks involve major bleeding, including gastrointestinal or intracranial hemorrhage

• Avoid use in patients with active bleeding, severe liver disease, or hypersensitivity to Apixaban

• Use caution in patients with kidney impairment or concomitant medications that increase bleeding risk

• Inform your doctor about all other medications, including over-the-counter drugs and herbal supplements, before starting therapy

• Patients should report signs of unusual bleeding or bruising immediately.